See All AI raises $33M to advance its AI platform that generates 3D surgical images from 2D fluoroscopic X-rays, potentially reducing reliance on pre-op CT and MRI scans.
Key Details
- 1See All AI secured $33 million in funding for its imaging AI platform.
- 2The system converts 2D C-arm fluoroscopic X-rays into 'navigable' 3D volumes.
- 3Aims to reduce the need for pre-operative CT and MRI imaging.
- 4Platform is designed to support minimally invasive surgery workflows.
- 5Technology is not yet FDA-cleared or available clinically; U.S. approval sought this year.
- 6Cadaver studies show capability for high-resolution, cross-plane, 1 mm 3D slices.
Why It Matters
If successful, this technology could streamline surgical planning and reduce costs, radiation, and time in the operating room. It highlights growing industry investment and innovation aimed at augmenting or replacing traditional radiology workflows in perioperative imaging.
Source
Radiology Business
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•AuntMinnie
AI Increases Lung Nodule Detection on LDCT but Not Speed
AI assistance raised detection rates of actionable lung nodules on LDCT but did not reduce interpretation time for radiologists.
•Radiology Business
Prospective Study Confirms AI Boosts Lung Nodule Detection in CT Screening
A new prospective trial finds AI assistance significantly increases detection of suspicious lung nodules in low-dose chest CT screenings.